glenzocimab (ACT 017) - Acticor Biotech
https://journals.sagepub.com/doi/reader/10.1177/17474930231192010
 
M. Köhrmann1; A. Comenducci2; Y. Plétan2; A. Meilhoc3; E.Toledano4; S. Binay4; G. Avenard5; J. Grotta6
 
Sep 9, 2023
 
Prev Next